EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Early onset thyroid dysfunction after irradiation of head-and-neck squamous cell cancer: A prospective observational study

Suditi Gupta, Abhidha Malik, Ratika Gupta, Vikas Yadav, Jaspreet Kaur, Akhilesh Mishra, Astha Srivastava

Annals of Oncology Research and Therapy · 2027

DOI: 10.4103/aort.aort_12_26 ↗
AbstractBibliografische Angaben

Abstract

Abstract: BACKGROUND: Radiation therapy (RT) for squamous cell carcinoma of the head and neck (SCCHN) frequently exposes the thyroid gland to significant radiation doses, predisposing patients to radiation-induced hypothyroidism (RIHT). Early thyroid dysfunction is often under-recognized. This study aimed to evaluate the occurrence and predictors of early-onset RIHT within 6 months of RT completion. MATERIALS AND METHODS: This prospective observational study included 80 patients with stage I–IVb SCCHN and normal baseline thyroid function. Patients received definitive or adjuvant RT (60–70 Gy in 2 Gy fractions) with or without concurrent chemotherapy. Thyroid function tests (thyroid-stimulating hormone [TSH], total T3, and T4) were performed at baseline, 3 months, and 6 months posttreatment. Statistical analysis was conducted using SPSS v28, with P < 0.05 considered statistically significant. RESULTS: The mean age was 49.8 ± 11.07 years, with a male predominance (91%). A significant progressive rise in mean TSH levels was observed at 3 and 6 months compared to baseline ( P = 0.002), while T3 and T4 levels remained stable. Subclinical hypothyroidism (SHT) occurred in 3.7% of patients at 3 months and increased to 8% at 6 months. Higher occurrence was observed in patients aged ≥40 years, those with laryngeal or oropharyngeal primaries, and those receiving radiation doses ≥54 Gy. CONCLUSION: Early SHT was detected in 8% of patients within 6 months of RT. Radiation dose ≥54 Gy emerged as the most consistent predictor, supporting routine thyroid monitoring and careful planning to minimize radiation exposure to the thyroid gland in head-and-neck radiotherapy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →